FBR Capital Initiates Genocea Biosciences With Outperform

FBR Capital initiated coverage on Genocea Biosciences Inc (NASDAQ: GNCA) with a Outperform rating.

The target price for Genocea Biosciences is set to $20.

Genocea Biosciences shares have dropped 35.12 percent over the past 52 weeks, while the S&P 500 index has surged 11.75 percent in the same period.

Genocea Biosciences' shares climbed 0.31 percent to close at $12.93 yesterday.